Anti-anginal drugs: Systematic review and clinical implications.

[1]  F. Crea,et al.  Anti-anginal drugs–beliefs and evidence: systematic review covering 50 years of medical treatment , 2018, European heart journal.

[2]  F. Crea,et al.  Expert consensus document: A 'diamond' approach to personalized treatment of angina , 2018, Nature Reviews Cardiology.

[3]  A. Rigby,et al.  Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials , 2018, European heart journal.

[4]  U. Thadani,et al.  Drug Therapy for Stable Angina Pectoris , 2017, Drugs.

[5]  J. Camm,et al.  Medical treatment of stable angina: A tailored therapeutic approach. , 2016, International journal of cardiology.

[6]  U. Thadani.  Management of Stable Angina – Current Guidelines: A Critical Appraisal , 2016, Cardiovascular Drugs and Therapy.

[7]  J. Camm,et al.  Management of stable angina: A commentary on the European Society of Cardiology guidelines , 2016, European journal of preventive cardiology.

[8]  A. Camm,et al.  Unresolved issues in the management of chronic stable angina. , 2015, International journal of cardiology.

[9]  Lung-Chuang Wang,et al.  The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris , 2014, Pharmacoepidemiology and drug safety.

[10]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[11]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[12]  B. Gersh,et al.  ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .

[13]  M. Tendera,et al.  Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris , 2012, Drugs.

[14]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[15]  Zhan-quan Li,et al.  Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[16]  Comparison of the antiischaemic and antianginal effects of nicorandil and amlodipine in patients with symptomatic stable angina pectoris: the SWAN study , 2007 .

[17]  Jean-Claude Tardif,et al.  Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. , 2005, European heart journal.

[18]  G. Cocco,et al.  Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris. , 2005, The American journal of cardiology.

[19]  N. Koylan,et al.  Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease. The Turkish trimetazidine study (TTS) , 2004, Acta cardiologica.

[20]  R. Hall,et al.  A Double-Blind, Parallel-Group Study of Amlodipine versus Long-Acting Nitrate in the Management of Elderly Patients with Stable Angina , 2001, Cardiology.

[21]  I. Ringqvist,et al.  Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris , 2000, Clinical cardiology.

[22]  K. McDonald,et al.  Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. , 2000, JAMA.

[23]  K. McDonald,et al.  Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina , 1999 .

[24]  H. Dargie,et al.  Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group. , 1994, British journal of clinical pharmacology.

[25]  P. Blin,et al.  A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris. , 1993, European heart journal.

[26]  Megan E. Pahmier,et al.  Double Blind , 2001, International Psychogeriatrics.